GlassScriptPhysician profile
Alejandra Uchio
NPI 1144217191
$3,872.10
in general payments reported to CMS, 2019-2025
18 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $176 · 2021: $619 · 2022: $724 · 2023: $653 · 2024: $986 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,820 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,820.45 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $897.20 | 2019-2025 | Rocklatan, Clareon, Simbrinza |
| Sun Pharmaceutical Industries INC. | $627.68 | 2019-2024 | Cequa |
| New World Medical,INC. | $500.00 | 2021 | |
| Bausch & Lomb Americas INC. | $462.16 | 2023-2024 | Miebo, Xiidra, Vyzulta |
| Oyster Point Pharma, INC. | $311.57 | 2022-2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $229.36 | 2019-2023 | |
| Abbvie INC. | $160.53 | 2022-2025 | |
| Glaukos Corporation | $98.59 | 2021-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Astellas Pharma Global Development | $98.24 | 2024 | Izervay |
| Harrow Eye, LLC | $92.52 | 2024-2025 | Vevye |
| Amgen INC. | $91.95 | 2024-2025 | Tepezza |
| Allergan, INC. | $87.73 | 2019 | |
| Horizon Therapeutics Plc | $73.37 | 2021-2023 | Tepezza |
| Thea Pharma INC. | $36.31 | 2022-2023 | |
| Eyepoint US, INC. | $32.19 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $31.94 | 2019 | |
| Mallinckrodt Hospital Products INC. | $23.59 | 2022 | |
| Beaver-Visitec International, INC. | $17.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandra Uchio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.